Frontiers in Cardiovascular Medicine

MARCH 10, 2024

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients. 3.45) and 4.47 (95% CI: 2.54–7.87),

Myocardial Infarction 59

Myocardial Infarction Cardiogenic Shock Article STEMI 59

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundClinical outcome of ischemic cardiogenic shock (CS) requiring extracorporeal membrane oxygenation is highly variable, necessitating appropriate assessment of prognosis. Journal of the American Heart Association, Ahead of Print. Fifteen parameters were selected to assess in‐hospital mortality.

Cardiogenic Shock 45

Cardiogenic Shock Hospital Myocardial Infarction Kidney Disease 45

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundCardiogenic shock carries high mortality. male, 67% acute myocardial infarction, 33% acute decompensated heart failure), 45 (41.3%), 33 (30.3%), and 31 (28.4%) were in SCAI Shock Stages C, D, and E, respectively. A suggestive trend of improving 30day survival was observed (56.8%, 63.9%, and 72.2%

Cardiogenic Shock 40

Cardiogenic Shock Best Practices Myocardial Infarction Pulmonary 40

European Journal of Heart Failure

JANUARY 14, 2025

The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.

Myocardial Infarction 40

Myocardial Infarction Bicuspid/Mitral Cardiogenic Shock Risk Factors 40

Open Heart

JUNE 5, 2024

We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. The primary outcome was 30-day mortality. Secondary outcomes included in-hospital and 30-day events. Patients with coronary artery disease were excluded.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

The American Journal of Cardiology

OCTOBER 11, 2024

Publication date: Available online 11 October 2024 Source: The American Journal of Cardiology Author(s): Carlos Diaz-Arocutipa, Norma Nicole Gamarra-Valverde, Rafael Salguero, Roberto Martín-Asenjo, Lourdes Vicent

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes 40

DAIC

FEBRUARY 29, 2024

This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

The British Journal of Cardiology

APRIL 16, 2024

As a low-volume PCI centre in the Middle East, we wanted to find out if the outcomes of our PCI procedures are different from those of high-volume PCI centres in the UK and the Western world. Prospectively collected data of all comers for PCI (urgent and elective) were retrospectively analysed. and the average number of stents 2.6.

Outcomes 40

Outcomes Cardiogenic Shock Angina STEMI 40

Circulation: Cardiovascular Quality & Outcomes

JANUARY 5, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Admissions to CICUs with the highest tertile of CCRx utilization had a greater burden of comorbidities, had more diagnoses of ST–elevation myocardial infarction, cardiac arrest, or cardiogenic shock, and had higher Sequential Organ Failure Assessment scores.

Critical Care 40

Critical Care Cardiogenic Shock Academic Cardiac Arrest 40

Dr. Smith's ECG Blog

NOVEMBER 3, 2023

The notes now refer to the patient being in cardiogenic shock, on pressors. hours from presentation, where he was found to have an acute thrombotic LAD occlusion which was stented with resulting TIMI 3 flow, but still the patient was in severe cardiogenic shock. Time = 3 hours: the next troponin returns at 60 ng/L.

Chest Pain 82

Chest Pain Cardiogenic Shock Ischemia Myocardial Infarction 82

Dr. Smith's ECG Blog

MAY 30, 2023

Literature cited In inferior myocardial infarction, neither ST elevation in lead V1 nor ST depression in lead I are reliable findings for the diagnosis of right ventricular infarction Johanna E. Such an escape would have a wider complex. Bischof , Christine I. Worrall , Stephen W. J Cardiol [Internet]. 2009;54:386–393.

Chest Pain 97

Chest Pain Myocardial Infarction STEMI Cardiogenic Shock 97

European Journal of Heart Failure

FEBRUARY 16, 2025

Organ perfusion pressure as a predictor of outcomes in cardiogenic shock: insights from the Altshock-2 registry. ABSTRACT Aims The diagnosis of cardiogenic shock (CS) relies upon signs and/or symptoms of end-organ hypoperfusion. The primary outcome was in-hospital all-cause mortality.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Myocardial Infarction Heart Failure 40

Journal of the American Heart Association

MARCH 7, 2025

BackgroundPatients with severe mitral regurgitation and cardiogenic shock demonstrate a poor prognosis. The primary outcome was device success and allcause death, while secondary outcomes included myocardial infarction, stroke, and heart failure hospitalization rates at 30day and intermediateterm followup.

Cardiogenic Shock 45

Cardiogenic Shock Bicuspid/Mitral Myocardial Infarction Heart Failure 45

Dr. Smith's ECG Blog

NOVEMBER 4, 2022

New insights into the use of the 12-lead electrocardiogram for diagnosing acute myocardial infarction in the emergency department. An elderly man with sudden cardiogenic shock, diffuse ST depressions, and STE in aVR Literature 1. 2 cases of Aortic Stenosis: Diffuse Subendocardial Ischemia on the ECG. Left main?

Ischemia 52

Ischemia STEMI Stenosis Chest Pain 52

DAIC

DECEMBER 14, 2023

Henry Ford Health's National Cardiogenic Shock Initiative research team. Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply. This can cause those organs to eventually stop functioning.

Cardiogenic Shock 105

Cardiogenic Shock Heart attacks Heart Attack Myocardial Infarction 105

Dr. Smith's ECG Blog

OCTOBER 24, 2019

were pretty sick, with mostly LM/pLAD lesions and high rates of cardiogenic shock. Outcome of our case Once the type 2 SCAD was identified, the heparin drip was stopped. Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction. Lobo et al.

Chest Pain 52

Chest Pain SCAD STEMI Cardiogenic Shock 52

Circulation: Heart Failure

MARCH 5, 2025

BACKGROUND:There are limited large-scale data on the outcomes of patients with cardiogenic shock (CS) transferred to hub centers. Circulation: Heart Failure, Ahead of Print. Overlap propensity score weighting was performed to assess the association between transfer status and in-hospital mortality.

Cardiogenic Shock 56

Cardiogenic Shock Hospital Outcomes Myocardial Infarction 56

Circulation: Cardiovascular Interventions

JANUARY 31, 2024

BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. The incidence of the primary safety outcome was 10.1% pharmacoinvasive and 46.2% pharmacoinvasive and 46.2%

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Cardiovascular Interventions 40

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

Background Data are lacking on the effects of the alternation of P2Y12 receptor antagonists (P2Y12) on bleeding and outcome in patients with myocardial infarction (MI) with cardiogenic shock (CS). Conclusion Our results suggest that the choice of P2Y12 was not associated with treatment outcome.

Cardiogenic Shock 59

Cardiogenic Shock Myocardial Infarction Outcomes 59

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). Nevertheless, data concerning the impact of anemia and ID on clinical outcome in patients with CS are scarce.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

Circulation

NOVEMBER 11, 2024

Background:Cardiogenic shock (CS) has high morbidity and mortality rates.

Myocardial Infarction 40

Myocardial Infarction Inpatient Cardiogenic Shock Cardiac Arrest 40

Journal of the American Heart Association

MARCH 21, 2025

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

COVID-19 40

COVID-19 Medicare Cardiogenic Shock Hospital 40

Open Heart

OCTOBER 7, 2024

Background Takotsubo cardiomyopathy (TC) is an established differential diagnosis of myocardial infarction with non-obstructive coronaries with significant interest but limited data on prognostication. We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC.

Inpatient 52

Inpatient Coronary Artery Bypass Graft Cardiomyopathy Cardiogenic Shock 52

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. Cardiogenic shock and acute ST-segment–elevation myocardial infarction are exclusions. Circulation: Cardiovascular Interventions, Ahead of Print.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

Journal of the American Heart Association

APRIL 16, 2025

The impact of age on the outcomes of patients undergoing highrisk percutaneous coronary intervention is limited. Patients 75 years of age had less diabetes and prior myocardial infarction, more hypertension and dyslipidemia, worse renal function, more severe valvular heart disease, but higher left ventricular ejection fraction (P<0.05

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Myocardial Infarction Aortic 40

Frontiers in Cardiovascular Medicine

OCTOBER 8, 2024

The primary outcome was 30-day MACE, including all-cause death, recurrent myocardial infarction, urgent target vessel revascularization, stroke, cardiogenic shock, and cardiac arrest (CA). The average age of the patients was 65.23 ± 12.66 years, The median AG levels were 7.60 mmol/L mmol/L (interquartile range: 6.30–10.20).

Chest Pain 52

Chest Pain Cardiogenic Shock Cardiac Arrest Myocardial Infarction 52

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

Assessment was severe sudden cardiogenic shock. In normal times, the most common use of cTni is in diagnosing, or ruling out, acute myocardial infarction (AMI, a subcategory of acute myocardial injury. Myocardial Infarction Type 2 and Myocardial Injury. They recorded an EC G: New ST Elevation.

Cardiac Arrest 52

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock 52

Dr. Smith's ECG Blog

MAY 8, 2023

Diagnosis of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block using the ST Elevation to S-Wave Ratio in a Modified Sgarbossa Rule. Electrocardiographic Diagnosis of Acute Coronary Occlusion Myocardial Infarction in Ventricular Paced Rhythm Using the Modified Sgarbossa Criteria.

Chest Pain 52

Chest Pain Myocardial Infarction STEMI Pacemaker 52

Dr. Smith's ECG Blog

JULY 18, 2014

such Q-waves are associated with larger MI and worse outcomes (2. So this patient likely has a several day old infarction, with persistent ST elevation and persistently upright T-waves. ng/ml and was falling, confirming infarction days ago. Very unlikely. Raitt et al.), Armstrong et al.), The initial troponin I was 23.7

STEMI 52

STEMI Pericarditis Myocardial Infarction Cardiogenic Shock 52

Dr. Smith's ECG Blog

FEBRUARY 5, 2019

LAD 80% mid LCx occluded mid (acute infarct lesion) RCA 80% mid. PCI mid LCx So this is an OMI (Occlusion Myocardial Infarction), but not a STEMI Echo: Decreased left ventricular systolic performance, mild/moderate. The patient went into cardiogenic shock and ultimately died of this MI. The cath lab was activated.

Myocardial Infarction 52

Myocardial Infarction Chest Pain Cardiogenic Shock STEMI 52

Dr. Smith's ECG Blog

AUGUST 9, 2019

At the bottom of the post, I have re-printed the section on aVR in my article on the ECG in ACS from the Canadian Journal of Cardiology: New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute Myocardial Infarction in the Emergency Department Case 1. Widimsky P et al. O'Gara PT, Kushner FG, Ascheim DD, et al.

Myocardial Infarction 52

Myocardial Infarction Ischemia STEMI Cardiogenic Shock 52

Dr. Smith's ECG Blog

NOVEMBER 26, 2018

The axiom of "type 1 (ACS, plaque rupture) STEMIs are not tachycardic unless they are in cardiogenic shock" is not applicable outside of sinus rhythm. Again, not an expected outcome with diltiazem). Diltiazem is not terribly effective for conversion of atrial flutter to sinus, so this should not be an expected result.

Ischemia 52

Ischemia Atrial Flutter Arrhythmia Tachycardia 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Wellnest

JULY 19, 2023

When one of these arteries becomes completely blocked by a blood clot, it results in a heart attack, also known as MI (Myocardial infarction). When a person experiences a heart attack or myocardial infarction, they may feel chest pain and other symptoms in different parts of their body.

Heart attacks 52

Heart attacks Heart Attack Blood Pressure Myocardial Infarction 52

Open Heart

DECEMBER 26, 2023

Objective This study describes the differences in treatment and clinical outcomes in patients aged ≥75 years compared with those aged ≤74 years presenting with acute coronary syndrome (ACS) and undergoing invasive management. Results In total, 11 763 patients were diagnosed with ACS, of which 39% were aged ≥75 years.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Angina 40

Frontiers in Cardiovascular Medicine

JANUARY 16, 2025

Although mortality risk prediction in cardiogenic shock (CS) is possible, assessing the impact of the multitude of therapeutic efforts on outcomes is not straightforward. were male and acute myocardial infarction was the prevalent cause of shock (71.1%). vs. 41.5%, p 4. CI: 0.230.82, p=0.83).

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Research 52